Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Ind-Swift Laboratories Ltd. Share Price
Day's Range
Day's Range
Low
₹132.90
High
₹136.40
Price Summary
| Previous Close | ₹133.89 |
|---|---|
| Day's Range | ₹132.90 - ₹136.40 |
| Open | ₹134.61 |
| 52 Week Range | ₹70.71 - ₹156.80 |
| Volume | 3,07,208 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 413.46 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 4.68 |
| TTM EPS (₹) | 28.63 |
| P/E Ratio | 2.30 |
| Book Value(₹) | 0.84 |
| PAT Margin (%) | 43.48 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 24.24 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1215.42 | 17091.5 |
| Expenses | N/A | N/A |
| PBT | -8.62 | 5977.31 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -8.62 | 5387.5 |
About Ind-Swift Laboratories Ltd.
| Founded | 1995 |
|---|---|
| Managing Director | Navrattan Munjal |
| NSE Symbol | INDSWFTLAB |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,51,074.97 | 1,879.90 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,79,485.96 | 6,755.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,124.14 | 4,386.00 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,201.01 | 8,077.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,640.69 | 1,431.55 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,589.46 | 1,336.95 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,03,966.32 | 2,273.90 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,03,368.09 | 2,507.00 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,02,190.60 | 1,050.05 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 1,01,755.41 | 1,011.25 | 835.50 - 835.50 |
No Records Found
Latest News
Ind-Swift Laboratories informs about disclosures
Ind-Swift Laboratories has informed that it enclosed disclosures received under Regulation 29(2) of SEBI (Substantial acquisition of Shares and Takeover) Regulations, 2011 received by the Company on 21st April, 2026 from HCP Investments.
The above information is a part of company’s filings submitted to BSE.
Ind-Swift Laboratories informs about disclosure
Ind-Swift Laboratories informs about analyst meet
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ind-Swift Laboratories has informed that One to One Investor meet with Seven Canyons Funds - Stock Pro Advisors is scheduleda on Monday, 2nd March, 2026 at 06:30 pm (after business hours). No Unpublished Price Sensitive Information is proposed to be shared by the Company during the aforesaid Analyst / Investor Meeting. This Disclosure is also made available on the website of the Company: https://www.indswiftlabs.com/investor.
The above information is a part of company’s filings submitted to BSE.
Senores Pharmaceuticals informs about press release
Rainbow Children's Medicare informs about board meeting
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Ind-Swift Laboratories Ltd. is ₹133.89 as of 2026-05-15.
The market capitalisation of Ind-Swift Laboratories Ltd. is ₹1,163.18 as of 2026-05-15.
The 1-year return of Ind-Swift Laboratories Ltd. is 0.00% as of 2026-05-15.
The P/E ratio of Ind-Swift Laboratories Ltd. is 2.30 as of 2026-05-16.
The 52-week high and low of Ind-Swift Laboratories Ltd. are ₹156.80 and ₹70.71, respectively, as of 2026-05-15.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
